| ISIN | LU0719899097 |
|---|---|
| Valor Number | 14685997 |
| Bloomberg Global ID | |
| Fund Name | Exane Equity Select Europe Fund B |
| Fund Provider |
Exane Asset Management
75008 Paris |
| Fund Provider | Exane Asset Management |
| Representative in Switzerland |
BNP Paribas, Paris, Zurich Branch Zürich |
| Distributor(s) | CREDIT SUISSE AG |
| Asset Class | Equities |
| EFC Category | |
| Distribution Policy | Accumulation |
| Home Country | Luxembourg |
| Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
| Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
| Investment Strategy *** | The Sub-Fund’s investment objective is to outperform its Benchmark Index over the recommended investment horizon. The Sub-Fund is intended for all categories of investors seeking an active investment approach to the European equity markets. |
| Peculiarities |
| Current Price * | 288.71 EUR | 11.11.2025 |
|---|---|---|
| Previous Price * | 284.36 EUR | 10.11.2025 |
| 52 Week High * | 288.71 EUR | 11.11.2025 |
| 52 Week Low * | 229.61 EUR | 09.04.2025 |
| NAV * | 288.71 EUR | 11.11.2025 |
| Issue Price * | ||
| Redemption Price * | ||
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 830,030,840 | |
| Unit/Share Assets *** | 43,904,169 | |
| Trading Information SIX | ||
| YTD Performance | +16.55% |
31.12.2024 - 11.11.2025
31.12.2024 11.11.2025 |
|---|---|---|
| YTD Performance (in CHF) | +15.00% |
31.12.2024 - 11.11.2025
31.12.2024 11.11.2025 |
| 1 month | +3.27% |
13.10.2025 - 11.11.2025
13.10.2025 11.11.2025 |
| 3 months | +7.42% |
11.08.2025 - 11.11.2025
11.08.2025 11.11.2025 |
| 6 months | +7.00% |
12.05.2025 - 11.11.2025
12.05.2025 11.11.2025 |
| 1 year | +15.90% |
11.11.2024 - 11.11.2025
11.11.2024 11.11.2025 |
| 2 years | +36.67% |
13.11.2023 - 11.11.2025
13.11.2023 11.11.2025 |
| 3 years | +41.55% |
11.11.2022 - 11.11.2025
11.11.2022 11.11.2025 |
| 5 years | +58.82% |
11.11.2020 - 11.11.2025
11.11.2020 11.11.2025 |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| AstraZeneca PLC | 3.77% | |
|---|---|---|
| Enel SpA | 3.51% | |
| SAP SE | 3.50% | |
| ASML Holding NV | 3.29% | |
| Siemens AG | 3.15% | |
| HSBC Holdings PLC | 3.03% | |
| Danone SA | 2.59% | |
| AXA SA | 2.52% | |
| Shell PLC | 2.37% | |
| Safran SA | 2.08% | |
| Last data update | 31.05.2025 | |
| TER | |
|---|---|
| TER date | |
| Performance Fee *** | 15.00% |
| PTR | |
| Max. Management Fee *** | 1.80% |
| Ongoing Charges *** | 1.94% |
|
SRRI ***
|
|
| SRRI date *** | 31.10.2025 |